Cargando…

Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation

Thermal ablation (TA) as an effective method treating hepatocellular carcinoma (HCC) in clinics is facing great challenges of high recurrence and metastasis. Although immune-checkpoint blockade (ICB)-based immunotherapy has shown potential to inhibit recurrence and metastasis, the combination strate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zecong, Li, Tan, Zheng, Xinyao, Lin, Liteng, Wang, Xiaobin, Li, Bo, Huang, Jingjun, Wang, Yong, Shuai, Xintao, Zhu, Kangshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399385/ https://www.ncbi.nlm.nih.gov/pubmed/36017073 http://dx.doi.org/10.1016/j.bioactmat.2022.07.027

Ejemplares similares

Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
por: Xiao, Zecong, et al.
Publicado: (2020)

Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
por: Lin, Liteng, et al.
Publicado: (2020)

Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Huang, Jingjun, et al.
Publicado: (2021)

T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma
por: Wang, Xiaobin, et al.
Publicado: (2023)

Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs‐Targeting Immunotherapy of Colon Cancer
por: Ding, Dongbing, et al.
Publicado: (2021)

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
por: Huang, Jingjun, et al.
Publicado: (2022)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation
por: Bei, Jiaxin, et al.
Publicado: (2023)

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
por: Huang, Jingjun, et al.
Publicado: (2021)

Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
por: Huang, Jingjun, et al.
Publicado: (2022)

High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Wen, Haopeng, et al.
Publicado: (2023)

Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
por: Zhu, Jianshu, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Cai, Mingyue, et al.
Publicado: (2022)

Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation
por: Huang, Tongyi, et al.
Publicado: (2023)

Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases
por: Liu, Mingyu, et al.
Publicado: (2023)

Reducing Postoperative Recurrence of Early‐Stage Hepatocellular Carcinoma by a Wound‐Targeted Nanodrug
por: li, Bozhao, et al.
Publicado: (2022)

Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways
por: Lin, Liteng, et al.
Publicado: (2018)

Nanodrugs Detonate Lysosome Bombs
por: Xiang, Yuting, et al.
Publicado: (2022)

Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation
por: Shen, Jian, et al.
Publicado: (2021)

Nanodrugs: pharmacokinetics and safety
por: Onoue, Satomi, et al.
Publicado: (2014)

CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
por: Chang, Yun, et al.
Publicado: (2023)

Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
por: Katopodi, Theodora, et al.
Publicado: (2023)

Camptothecin-based nanodrug delivery systems
por: Wen, Yan, et al.
Publicado: (2017)

Nanodrugs systems for therapy and diagnosis of esophageal cancer
por: Zhang, Lihan, et al.
Publicado: (2023)

Nanodrugs and Natural Pharmaceutical Products
por: Abbaspour, Mohammadreza
Publicado: (2012)

CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation
por: Wang, Xiong B, et al.
Publicado: (2011)

Activation, Amplification, and Ablation as Dynamic Mechanisms of Dendritic Cell Maturation
por: Bourque, Jessica, et al.
Publicado: (2023)

Nanodrugs Reprogram Cancer-Associated Fibroblasts and Normalize Tumor Vasculatures for Sequentially Enhancing Photodynamic Therapy of Hepatocellular Carcinoma
por: Fei, Bingyuan, et al.
Publicado: (2023)

Engineered protein nanodrug as an emerging therapeutic tool
por: Li, Yuanxin, et al.
Publicado: (2022)

Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells
por: Wang, Ying, et al.
Publicado: (2018)

Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy
por: Chen, Xing, et al.
Publicado: (2021)

Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment
por: Chen, Qiaohui, et al.
Publicado: (2022)

Osteopontin promotes dendritic cell maturation and function in response to HBV antigens
por: Cui, Guangying, et al.
Publicado: (2015)

Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine
por: Shi, Gao-Na, et al.
Publicado: (2021)

Nanodrug-Enhanced Radiofrequency Tumor Ablation: Effect of Micellar or Liposomal Carrier on Drug Delivery and Treatment Efficacy
por: Moussa, Marwan, et al.
Publicado: (2014)

Revolutionary Impact of Nanodrug Delivery on Neuroscience
por: Khanbabaie, Reza, et al.
Publicado: (2012)

Nanodrugs Targeting T Cells in Tumor Therapy
por: Haist, Maximilian, et al.
Publicado: (2022)

Hepatocellular carcinoma-associated antigen 59 of Haemonchus contortus modulates the functions of PBMCs and the differentiation and maturation of monocyte-derived dendritic cells of goats in vitro
por: Wang, QiangQiang, et al.
Publicado: (2019)

Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
por: Lu, Yilei, et al.
Publicado: (2022)

STIM1 promotes migration, phagosomal maturation and antigen cross-presentation in dendritic cells
por: Nunes-Hasler, Paula, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5h1ss2earm5qigb0lnlkullku4